Further, many scientific groups have demonstrated that various HDAC inhibitors targeting global HDAC activity or single HDAC enzymes decreased lung fibrosis and ECM deposition in bleomycin-treated mice [164,168,169,170,171]. Here, HDAC9 is linked to pulmonary fibrosis.